{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-115911","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.588674+00:00","generated_at":"2026-05-30T02:55:19.141231+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Aprea Therapeutics enters ATM equity offering agreement for up to $3.0M with H.C. Wainwright","bullets":["Aprea entered into an at-the-market offering agreement with H.C. Wainwright to sell up to $3.0M of common stock.","HCW will serve as sales agent and receive a 3.0% commission on gross proceeds from sales.","Net proceeds will fund general corporate purposes, including preclinical studies and clinical trials.","The company is not obligated to sell any shares under the agreement; sales may occur from time to time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-115911","json":"https://secwatch.observer/filing/0001104659-24-115911.json","markdown":"https://secwatch.observer/filing/0001104659-24-115911.md","text":"https://secwatch.observer/filing/0001104659-24-115911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/0001104659-24-115911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/tm2427608d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:55:19.141231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}